Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Cov2, Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04355351
What this trial is testing

Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)

Who this might be right for
New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2
Centre Hospitalier Universitaire de Nice 303
Not applicableUnknownNCT04836793
What this trial is testing

COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2

Who this might be right for
CancerElderlyHealthy Aging
Centre Hospitalier Universitaire de Besancon 300
Not applicableLooking for participantsNCT06848309
What this trial is testing

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

Who this might be right for
InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Washington University School of Medicine 300
Not applicableActive Not RecruitingNCT05110911
What this trial is testing

Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection

Who this might be right for
Influenza, HumanSARS-CoV-2 Infection
University of Melbourne 1,500
Not applicableStudy completedNCT04590352
What this trial is testing

Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients

Who this might be right for
SARS-CoV-2 Infection
Radboud University Medical Center 187
Testing effectiveness (Phase 2)Study completedNCT04358406
What this trial is testing

Rhu-pGSN for Severe Covid-19 Pneumonia

Who this might be right for
Sars-CoV2
BioAegis Therapeutics Inc. 64
Not applicableEnrolling By InvitationNCT06401720
What this trial is testing

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection

Who this might be right for
Influenza A InfectionInfluenza B Virus InfectionSARS CoV 2 Infection+1 more
Karolinska Institutet 800
Not applicableActive Not RecruitingNCT05078905
What this trial is testing

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

Who this might be right for
COVID-19VaccinationHealthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 103
Not applicableUnknownNCT05689177
What this trial is testing

Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19

Who this might be right for
Humoral Immunity
Gomel State Medical University 100
Not applicableLooking for participantsNCT04392401
What this trial is testing

COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study

Who this might be right for
Intensive Care UnitSARS-Cov-2
Hospices Civils de Lyon 200
Early research (Phase 1)UnknownNCT05007275
What this trial is testing

Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Who this might be right for
Covid19SARS-CoV-2 Infection
Imperial College London 28
Early research (Phase 1)Study completedNCT04773665
What this trial is testing

Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Who this might be right for
Covid19
VBI Vaccines Inc. 114
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Not applicableStudy completedNCT05589233
What this trial is testing

COVID-19 Vaccination AZV 2021-2023

Who this might be right for
COVID-19VaccinationImmunity+1 more
University Hospital Hradec Kralove 3,000
Post-approval studies (Phase 4)Ended earlyNCT05075538
What this trial is testing

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

Who this might be right for
Cancer
Jules Bordet Institute 152
Not applicableUnknownNCT04987554
What this trial is testing

Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2

Who this might be right for
SARS-CoV-2 Infection
University of Valladolid 120
Post-approval studies (Phase 4)Study completedNCT04414267
What this trial is testing

Bacillus Calmette-guérin Vaccination to Prevent COVID-19

Who this might be right for
COVID-19Virus DiseasesCorona Virus Infection+2 more
Hellenic Institute for the Study of Sepsis 301
Large-scale testing (Phase 3)Ended earlyNCT05593770
What this trial is testing

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Who this might be right for
COVID-19SARS-CoV2 InfectionCoronavirus Infection
NEAT ID Foundation 28
Not applicableStudy completedNCT04817280
What this trial is testing

COVID-19 in Polish Ice Swimmers.

Who this might be right for
Covid19SARS-CoV InfectionResistance, Disease+2 more
Wroclaw Medical University 2,534
Post-approval studies (Phase 4)Study completedNCT04952402
What this trial is testing

SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine

Who this might be right for
Covid19SARS-CoV2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 43
Next Page